Regiocit solution pour hémofiltration
APHP220257
Approved small_molecule active
Quick answer
Regiocit solution pour hémofiltration for Adult patients hospitalized in intensive care with an indication of EER with ARC during the stay. is a Approved program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adult patients hospitalized in intensive care with an indication of EER with ARC during the stay.
- Phase
- Approved
- Modality
- small_molecule
- Status
- active